(Q39525496)

12 September 2017

title

Establishment, characterization, and successful adaptive therapy against human tumors of NKG cell, a new human NK cell line (English)

1 reference

12 September 2017

Min Cheng

1

1 reference

12 September 2017

Juan Ma

2

1 reference

12 September 2017

Yongyan Chen

3

1 reference

12 September 2017

Jianhua Zhang

4

1 reference

12 September 2017

Weidong Zhao

5

1 reference

12 September 2017

Jian Zhang

6

1 reference

12 September 2017

Haiming Wei

7

1 reference

12 September 2017

Bin Ling

8

1 reference

12 September 2017

Rui Sun

9

1 reference

12 September 2017

Zhigang Tian

10

1 reference

12 September 2017

language of work or name

1 reference

7 June 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

20

1 reference

12 September 2017

issue

11-12

1 reference

12 September 2017

page(s)

1731-1746

1 reference

Chimeric NKG2D expressing T cells eliminate immunosuppression and activate immunity within the ovarian tumor microenvironment

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Cellular immunotherapy for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Impaired function of hepatic natural killer cells from murine chronic HBsAg carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Immunotherapy opportunities in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Letal, A tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Electron microscopic study of natural killer cell-tumor cell conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Innate immune recognition and suppression of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Establishment of an IL-2-dependent cell line derived from 'nasal-type' NK/T-cell lymphoma of CD2+, sCD3-, CD3epsilon+, CD56+ phenotype and associated with the Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Inhibition of human ovarian tumor growth by cytokine-induced killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Ex vivo expansion of natural killer cells for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Artificial cells for the development of cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Natural killer cell receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Prospects for the use of NK cells in immunotherapy of human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

New aspects of natural-killer-cell surveillance and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Irradiated KHYG-1 retains cytotoxicity: potential for adoptive immunotherapy with a natural killer cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Immunotherapy of malignant melanoma in a SCID mouse model using the highly cytotoxic natural killer cell line NK-92.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Cellular Immunotherapy of Malignancies Using the Clonal Natural Killer Cell Line NK-92

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Natural killer cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

Comparison in the effects of IL-2, IL-12, IL-15 and IFNalpha on gene regulation of granzymes of human NK cell line NK-92.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368911X580536

21 January 2018

Identifiers

DOI

10.3727/096368911X580536

1 reference

12 September 2017

1 reference